Equivalent Dose Conversion: Cyclobenzaprine to Methocarbamol
There is no established equivalent dose conversion between cyclobenzaprine (Flexeril) 5 mg TID and methocarbamol, as these medications have different mechanisms of action and no direct dose equivalency has been validated in clinical trials. If switching is necessary, start methocarbamol at standard dosing (1500 mg QID or 750 mg TID-QID) rather than attempting a calculated conversion 1, 2.
Key Evidence on Comparative Efficacy
Cyclobenzaprine Efficacy
- Cyclobenzaprine 5 mg TID has been specifically studied and proven effective for acute musculoskeletal conditions, with efficacy equivalent to 10 mg TID but with lower sedation rates 3
- Cyclobenzaprine has been evaluated in the most clinical trials and consistently demonstrates effectiveness compared to placebo for musculoskeletal pain 1
Methocarbamol Efficacy
- Methocarbamol has very limited and inconsistent data regarding effectiveness compared to placebo for musculoskeletal conditions 1
- In a recent comparative study, methocarbamol showed the least improvement in disability scores (mean RMDQ improvement 8.1) compared to other muscle relaxants and was not superior to placebo 2
- Therapeutic concentrations of methocarbamol are reported as 24-41 mcg/mL, but this does not translate to a dose equivalency with cyclobenzaprine 4
Clinical Recommendation
If you must switch from cyclobenzaprine 5 mg TID to methocarbamol:
- Start methocarbamol at 1500 mg QID (standard dosing) or 750 mg TID-QID based on typical prescribing patterns 5
- Do not attempt mathematical dose conversion, as the medications work through different mechanisms
- Be aware that methocarbamol may be less effective than cyclobenzaprine for your patient's musculoskeletal condition 1, 2
Important Caveats
- Consider whether switching is truly necessary, as cyclobenzaprine 5 mg TID has superior evidence for efficacy in musculoskeletal conditions 3, 1
- If switching due to sedation concerns with cyclobenzaprine, note that the 5 mg TID dose already minimizes this adverse effect compared to higher doses 3
- Methocarbamol can potentiate CNS depression when combined with other sedating medications or alcohol 4
- Recent evidence suggests skeletal muscle relaxants as a class may not provide significant benefit over placebo when combined with NSAIDs 2